More than 200 private U.S. biotechs with $50 million or more in funding to date secured their last reported financing between three and five years...
Startups
The transaction and resulting valuation grant OpenAI the distinction of now being the world鈥檚 most valuable private, venture-backed company...
Current market conditions have challenged the reliability of IPOs, forcing many companies to reevaluate their paths to public markets, writes guest...
Shares of Neptune Insurance Holdings were up in early first-day trading Wednesday, as the market tides delivered a moderate rise for the flood...
![Money - Illustration of a giant piggybank with a woman looking at it. [Dom Guzman]](/wp-content/uploads/Big_Piggy_Bank-470x352.jpg)
Using Crunchbase data, we put together a sample list of 15 recently launched venture investors that are leading good-sized rounds, most of which have...
The old SaaS playbook of build a great app, charge monthly and let infrastructure fade into the background, doesn鈥檛 hold up when your core cost...
Alvys, an AI-powered logistics software provider, has raised $40 million in an RTP Global-led Series B funding, the company tells Crunchbase News...
The share of U.S. startup investment going to biotech companies has hit the lowest level in more than 20 years, as an ever-growing proportion of...
Mistimed market entry is one of the top five reasons startups fail, writes guest author Ashish Kakran of Sierra Ventures. While the perfect time to...
This week was a fairly busy one for large financings, with eight of the top 10 exceeding the $100 million mark. Leading the way were two software...
We鈥檙e entering an era where the most transformative value could be created almost entirely within private markets, widening the wealth gap between...
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers